Episcopal Relief & Development is working with the Episcopal Church of Cuba to respond to Hurricane Rafael, a powerful hurricane that devastated the northwestern side of the island in November. "Those ...

The company reached a tentative deal to recoup $1.7 billion of wildfire and mudslide expenses in California ... Pfizer Inc. (NYSE:PFE) is an American pharmaceutical company that mainly ...

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...

Let's look at six real-world reasons why companies stick with manual processes and how to tell when automation might be the ...

NEW YORK (PIX11) — New York City officials are urging residents to use caution if they spot a sick or dead bird. While the ...

Millie Bobby Brown spoke out in a Vanity Fair cover story about her film contracts leaking online. Reports surfaced in July ...

WEST LAFAYETTE, Ind. — Purdue University, in collaboration with Eli Lilly and Company and Merck & Co. Inc., announced Friday (Jan. 17) the launch of the Young Institute Pharmaceutical Manufacturing ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...

The rise of artificial intelligence (AI), digitalisation, wider adoption of tools for marketing automation, and numerous other technologies have significantly reshaped the world of pharma for the ...

The U.S. Food and Drug Administration approved a new prescription-strength pain reliever from Vertex Pharmaceuticals on Jan. 30, 2025. Journavx is a non-opioid drug that prevents peripheral nerves ...

HOUSTON and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company developing therapies for patients with ...